Ionis Pharmaceuticals, Inc. (IONS) financial statements (2022 and earlier)

Company profile

Business Address 2855 GAZELLE COURT
CARLSBAD, CA 92010
State of Incorp. CA
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments2,1151,8922,5002,0841,023665779
Cash and cash equivalents86939868327913085129
Short-term investments1,2461,4951,8161,805893581650
Receivables    6310811
Inventory, net of allowances, customer advances and progress billings2522189   
Inventory2522189   
Contract with customer, asset62766313
Other current assets143140140102721515
Other undisclosed current assets    101032
Total current assets:2,3452,1312,7212,2081,168798837
Noncurrent Assets
Property, plant and equipment1781811541321229390
Intangible assets, net (including goodwill)2928262422  
Intangible assets, net (excluding goodwill)2928262422  
Deferred income tax assets  306
Other noncurrent assets6050281310  
Deferred tax assets, net291   
Other undisclosed noncurrent assets     2229
Total noncurrent assets:267259513460154115119
TOTAL ASSETS:2,6122,3903,2332,6681,322912956
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1391741531061178173
Accounts payable12171629252128
Accrued liabilities89906748673628
Employee-related liabilities39663729252416
Taxes payable0133    
Deferred revenue98108118
Debt 300214211
Deferred revenue and credits1065167
Contract with customer, liability160
Other undisclosed current liabilities4     9
Total current liabilities:241583273280225134149
Noncurrent Liabilities
Long-term debt and lease obligation, including:6053960628593  
Long-term debt, excluding current maturities606060628593  
Other undisclosed long-term debt and lease obligation 479     
Liabilities, other than long-term debt3524244905677391134
Deferred revenue and credits7391134
Deferred revenue352424490
Contract with customer, liability567
Other undisclosed noncurrent liabilities1,188 726513588472
Total noncurrent liabilities:1,5999631,2761,200679679606
Total liabilities:1,8401,5461,5491,481903813755
Stockholders' equity
Stockholders' equity attributable to parent7728431,4711,048331100201
Common stock0000000
Additional paid in capital1,9642,1142,2042,0471,5501,3111,309
Accumulated other comprehensive loss(33)(21)(25)(32)(32)(30)(14)
Accumulated deficit(1,160)(1,249)(708)(967)(1,187)(1,181)(1,095)
Stockholders' equity attributable to noncontrolling interest  21313988  
Total stockholders' equity:7728431,6851,187419100201
TOTAL LIABILITIES AND EQUITY:2,6122,3903,2332,6681,322912956

Income statement (P&L) ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues8107291,123600508347284
Revenue, net113  
Cost of revenue(11)(12)(4)(2)   
Cost of goods and services sold(11)(12)(4)(2)   
Gross profit:7997171,118598508347284
Operating expenses(830)(889)(752)(661)(483)(393)(359)
Other undisclosed operating income   2   
Operating income (loss):(30)(172)366(61)25(46)(76)
Nonoperating income19475230454
Investment income, nonoperating20475230854
Other nonoperating expense(1)(0)(1)(0)(4)  
Interest and debt expense(18)(45)(71)(45)(45)(43)(37)
Other undisclosed loss from continuing operations before equity method investments, income taxes    (7)  
Income (loss) from continuing operations before equity method investments, income taxes:(29)(170)347(76)(23)(84)(108)
Other undisclosed income from continuing operations before income taxes     020
Income (loss) from continuing operations before income taxes:(29)(170)347(76)(23)(84)(88)
Income tax expense (benefit)1(317)(44)2916(3)(0)
Net income (loss):(29)(487)303215(17)(87)(88)
Net income (loss) attributable to noncontrolling interest 35(9)5911  
Net income (loss) attributable to parent:(29)(451)294274(6)(87)(88)
Other undisclosed net income (loss) available to common stockholders, basic (0)2316  
Net income (loss) available to common stockholders, diluted:(29)(451)29727710(87)(88)

Comprehensive Income ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net income (loss):(29)(487)303215(17)(87)(88)
Other comprehensive income (loss)(12)47(0)(1)  
Comprehensive income (loss):(40)(483)310215(19)(87)(88)
Comprehensive income (loss), net of tax, attributable to noncontrolling interest 35(9)5911  
Other undisclosed comprehensive loss, net of tax, attributable to parent     (17)(53)
Comprehensive income (loss), net of tax, attributable to parent:(40)(447)301274(7)(103)(142)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: